Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » About Us » Our Staff » Justin Petrone

Justin Petrone

Contributor
Phone Number
+011-372-510-5093
Email
[email protected]

Justin Petrone covers consumer genomics, ancestry testing, and the microarray and biochip sector of the genomics market for GenomeWeb.

Articles Authored by Justin Petrone

Sep 10, 2020

Researchers Encourage Forensics Labs to Adopt New Genomic Technologies for Relationship Testing

Premium

Driving the shift is a belief that standard STR testing is not always a reliable tool for determining complex family relationships.

Sep 01, 2020

Immunexpress, Biocartis to Roll Out Sepsis Test in Europe Ahead of Planned US Launch

Premium

The companies are positioning the test, called SeptiCyte Rapid, for use in triaging COVID-19 patients who could be at greater risk for progressing to sepsis.

 

Aug 07, 2020

NHS Wales Introduces Whole-Genome Sequencing for Critically Ill Newborns, Children

Premium

The service is the first of its kind in the UK and relies on the Illumina NovaSeq 6000 platform to deliver results.

Aug 03, 2020

Ancestry Rolls Out Sequencing-Based Health Offering Focused on Common Conditions

Premium

The next iteration of Ancestry's Health experience seeks to provide customers with actionable information about certain commonly inherited health conditions.

Jul 24, 2020

Norwegian Diagnostics Firm Age Labs to Develop Epigenetics-Based Test for SARS-CoV-2

Premium

The Oslo-based company plans to develop a test that can identify high-risk individuals based on an epigenetic signature.

Jul 02, 2020

Genomics England, Sano, Zetta Building Platform to Support Rare Disease Patient Participation

Premium

The software tool, currently in development, is set to be introduced next year and could also find application in other indications such as cancer.

Jun 24, 2020

Genetic Study Explains Link Between Osteoporosis Drug, Cardiovascular Risk

The findings underscore the value of carrying out large-scale human genetic analyses as part of drug target identification and validation efforts. 

 

 

Jun 19, 2020

Improved Pool Testing Methods Could Enable COVID-19 Screening as Pandemic Continues

Premium

While new ways to carry out pool testing for SARS-CoV-2 abound, questions remain about sensitivity issues and the regulation of such tests.

Jun 17, 2020

Stilla Positions Six-Color Digital PCR System for Use in Oncology, Virology, GMO Testing

Premium

The launch of the company's Prism system earlier this month should support the development of an accompanying menu of tests to serve diverse users.

Jun 11, 2020

Diversity Problem Hinders Adoption of Polygenic Risk Scores, According to ESHG Panel

Polygenic risk scores have the potential to impact cancer screening, autoimmune disease testing, and therapeutics development, but more diverse data is needed.

The Scan

Plans Out

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

CovidNudge Numbers

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

Science Papers Propose Group to Discuss Genome-Editing Tools, Markers of Diabetes Drug Response, More

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

Not Counting These

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.